Medeon Biodesign (6499) — Capital Reinvestment Ratio
Medeon Biodesign (6499) has a Capital Reinvestment Ratio of 0.68x as of March 2022, meaning it reinvests 1% of its operating cash flow (NT$60.74 Million) in capital expenditures (NT$41.12 Million). See 6499 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Medeon Biodesign Capital Reinvestment Ratio (2018–2018)
This chart tracks Medeon Biodesign's Capital Reinvestment Ratio across 1 annual periods. Check 6499 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Medeon Biodesign (2018–2018)
Year-by-year Capital Reinvestment Ratio for Medeon Biodesign from 2018 to 2018. For live market cap and broader valuation context, see how much is Medeon Biodesign worth.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.16x | NT$322.05 Million | NT$51.14 Million | — |